Q: A comment rather than a question. What explains the 15% yield? Roughly a quarter of the payout for 2016 consists of a "capital gains dividend," rather than an eligible dividend. The portfolio itself produces dividends of which only a portion is used to cover the dividends of the preferred shares. The class A shares do not pay a dividend if the NAV of the total portfolio falls below $15, which happened in the recent past. However, over 2016 the Canadian and US financial holdings did very wel. The covered call options must have done very well also, but because of that the NAV seriously underperformed straightforward asset growth - compare FTN with ZEB and ZUB over the last year. So FTN's asset growth underperforms under bullish conditions. BTW, at the moment there seems to be a 30% premium on the NAV of FTN.
Q: Given an oustanding share count under 50 million per say, is it a significant event ( maybe a bit of a milestone )for a company to reach a $500M or $1B market cap. How significant is such an event to analysts or large investors?
Q: I'm a little disappointed at the $38 new issue price, close to the 52-week low after having touched $45 only six weeks ago. Nonetheless, would you have any concerns about taking a half position up to a full position on the pullback?
Q: How is it that Quadravest is able to keep generating a 15% annual return on this product. I know they use options to juice the dividend yield they get from the underlying companies. For 18 months from mid 2011 to end 2012 they did not pay a distribution on FTN so there is that risk. It just seems to me that this is one of those situations where it is to good to be true? Am I right to be wary of the product as I don't understand how they can maintain the high yield.
Q: CSH has dividends in something called CAPITAL DIVIDENDS. As I understand it, these dividends are not taxable. Does this mean the cost base goes down by this amount, or what? In a related question, is it best to hold CSH in an RSP (where I currently have my units) or in a taxable account. Should I sell CSH in the RSP and buy it back in the taxable account, adding something else into the RSP?
Q: I currently have ZQQ at a 5% weighting in most of my portfolios and I am considering replacing it with one or two US tech companies. My tech exposure in each portfolio is approximately 20% and I want to maintain that percentage. I have income tax consequences in most portfolios; taking this is account what stocks would you consider to have higher return potential than ZQQ over 5 to 10 years.
Q: Good afternoon
In 2016 I purchased FSV @ $57. It popped in February and I sold it @ 65 and made $10,000. It just keeps on going but I'm hesitant to get back in because the PE is 65.
Any thoughts?
Thanks
Q: I purchased today 10000 shares of HXD. I consider it like an insurance policy in the event of a bear market to cover my long positions. Is this a reasonable approach?
Q: Hello Peter and team, I know you like Endbridge (ENB)very much, you actually have it in two of your model portfolios. According to TMX Money, ENB has a yield of 4.2% and a P/E ratio of 28.0. On the other hand ENF has a yield of 6.2% and a P/E ratio of 15.2. If you had to invest in just one of them today, would you still select ENB rather than ENF? If yes, could you comment on the rationale for doing so. Regards, Gervais
Q: I have not tendered my shares as yet. Currently NXPI is trading within 5% of closing price which I would have to wait to year end to see. Should I quibble about this and tender to collect the 5% or just sell outright for the cash on hand? Waiting to date has certainly paid off if I were to buy QCOM shares today with the proceeds but I don't expect any further widening of that spread.
Q: I reviewed analyses from investing letters services, including Sabrient, New Constructs and GuruFocus. I also read through materials available from the well known financial sites such as Yahoo Finance and Thompson Reuters. I am used to seeing opinions and projections that cover the spectrum-- from excellent to disaster.
On CBRL.us however it looks like analysts are either at one extreme or the other. CFAs are generally not dumb and the opinions being clustered at the extremes puzzles me. Please give your insight and opinion. Although CBRL would not be a ‘must have’ it was recently added by AAII to its model dividend folio. And, after some back tests I now try to follow its models. AAII also advises members to include all its selections. Notwithstanding that advice , I don’t always add a stock AAII likes if for example I lack confidence in some criteria they used. AAII would not however have been casual about this recent selection
In your response, I am looking more for your insight or substance , with your thoughts and instincts, your opinion or thoughts on the future of the industry, and the prospects for the specific company. Thank you.